Role of Beta-Catenin Signaling in Osteoblast Function
Role of Beta-Catenin Signaling in Osteoblast Function
批准号:
6838605
负责人:
Robert Nissenson
金额:
$8.25万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2006-06-30
关键词:
apoptosisbiological signal transductionbone developmentbone metabolismcadherinscell differentiationcell growth regulationcell population studycell proliferationcomputed axial tomographygene expressiongene targetinggenetically modified animalshormone receptorhormone regulation /control mechanismlaboratory mouselow density lipoprotein receptormitogensosteoblastsparathyroid hormonespathologic bone resorptionphysiologic bone resorption
中文摘要
描述(由申请人提供):
最近的遗传学证据表明LRP 5在支持骨形成中起关键作用,这提供了强有力的推定证据,即经典wnt信号通路是成骨细胞骨形成的主要调节因子。本提案是为解决这一条例的机制和范围而作出的努力。这将通过在成年小鼠中开发受控基因敲除的体内系统来实现,并将其应用于成骨细胞谱系细胞中β-连环蛋白基因的靶向敲除。我们假设成骨细胞中的经典wnt信号通过不同的机制在成骨细胞分化的不同阶段对骨形成产生积极的影响,增加早期成骨细胞的增殖,抑制完全分化成骨细胞的凋亡。我们还假设甲状旁腺激素(PTH)的合成代谢作用是通过PTH受体信号传导的能力来增强经典WNT信号传导的合成代谢作用。为了验证这些假设,我们建议首先确定典型的wnt/LRP通路在前成骨细胞和成熟成骨细胞的β-连环蛋白表达调控敲除的差异作用。四环素调控系统将被用于允许cre重组酶在体内成骨细胞中的受控表达。使用3.6kb和2.3kb I型胶原启动子将允许我们在前成骨细胞和成熟成骨细胞(3.6kb启动子)中或仅在成熟成骨细胞(2.3kb启动子)中消除β-连环蛋白。我们将通过microCT确定β-连环蛋白的诱导敲除对骨骼稳态的影响,以及对增殖和凋亡的成骨细胞数量的影响。在初步研究中,我们发现PTH受体信号传导与β-连环蛋白协同激活LEF/TCF转录因子,经典wnt信号传导的下游靶标。因此,我们将使用β-连环蛋白敲除模型来确定这种会聚信号传导是否是外源性PTH合成代谢作用的重要途径。这些研究的成功完成将有助于确定经典wnt信号在骨骼功能中的作用,并将为PTH合成代谢作用的机制提供新的见解。
英文摘要
DESCRIPTION (provided by applicant):
The recent genetic evidence that LRP5 plays a key role in supporting bone formation provides strong presumptive evidence that the canonical wnt signaling pathway is a primary regulator of osteoblastic bone formation. The present proposal constitutes an effort to address the mechanism and scope of this regulation. This will be accomplished by developing an in vivo system of controlled gene knockout in adult mice, and applying this to the targeted knockout of the beta-catenin gene in osteoblast lineage cells. We hypothesize that canonical wnt signaling in osteoblasts produces a positive effect on bone formation via different mechanisms at different stages of osteoblast differentiation, increasing proliferation in early osteoblasts and inhibiting apoptosis in fully differentiated osteoblasts. We also hypothesize that the anabolic action of parathyroid hormone (PTH) is exerted via the ability of PTH receptor signaling to potentiate the anabolic action of canonical wnt signaling. To test these hypotheses, we propose to first determine the differential role of the canonical wnt/LRP pathway in preosteoblasts and in mature osteoblasts by regulated knockout of beta-catenin expression. The tetracycline regulatory system will be used to allow for controlled expression of the cre recombinase in osteoblasts in vivo. The use of the 3.6 kb and 2.3 kb type I collagen promoters will allow us to ablate beta-catenin in pre-osteoblasts and mature osteoblasts (3.6 kb promoter) or only in mature osteoblasts (2.3 kb promoter). We will determine the effect of induced knockout of beta-catenin on skeletal homeostasis by microCT and on the number of osteoblasts undergoing proliferation and apoptosis. In preliminary studies, we have found that PTH receptor signaling synergizes with beta-catenin in the activation of LEF/TCF transcription factors, the downstream target of canonical wnt signaling. We will therefore use the beta-catenin knockout model to determine whether this convergent signaling is an essential pathway for the anabolic effect of exogenous PTH. Successful completion of these studies will help to define the role of canonical wnt signaling in skeletal function, and will provide novel insights into the mechanism underlying the anabolic effects of PTH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of Bone Mass by Progranulin
-
批准号:10509393
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Robert Nissenson
-
依托单位:
Control of Bone Mass by Progranulin
-
批准号:10368564
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Robert Nissenson
-
依托单位:
G Protein Signaling in Osteoblasts
-
批准号:8413401
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Nissenson
-
依托单位:
G Protein Signaling in Osteoblasts
-
批准号:8598065
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Nissenson
-
依托单位:
G Protein Signaling in Osteoblasts
-
批准号:8246342
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Robert Nissenson
-
依托单位:
G PROTEIN SIGNALING IN OSTEOBLASTS
-
批准号:7334720
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2006
-
负责人:Robert Nissenson
-
依托单位:
G PROTEIN SIGNALING IN OSTEOBLASTS
-
批准号:7172997
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2006
-
负责人:Robert Nissenson
-
依托单位:
G PROTEIN SIGNALING IN OSTEOBLASTS
-
批准号:7564676
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2006
-
负责人:Robert Nissenson
-
依托单位:
G PROTEIN SIGNALING IN OSTEOBLASTS
-
批准号:7049877
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2006
-
负责人:Robert Nissenson
-
依托单位:
G Protein Signaling in Osteoblasts
-
批准号:8038528
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2005
-
负责人:Robert Nissenson
-
依托单位:
Role of Beta-Catenin Signaling in Osteoblast Function
-
批准号:6953242
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2004
-
负责人:Robert Nissenson
-
依托单位:
2003 Bones & Teeth Gordon Conference
-
批准号:6700484
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2003
-
负责人:Robert Nissenson
-
依托单位:
CLONING OF THE PARATHYROID HORMONE RECEPTOR CDNA
-
批准号:2142125
-
项目类别:
-
资助金额:$9.32万
-
财政年份:1991
-
负责人:Robert Nissenson
-
依托单位:
CLONING OF THE PARATHYROID HORMONE RECEPTOR CDNA
-
批准号:3243173
-
项目类别:
-
资助金额:$7.93万
-
财政年份:1991
-
负责人:Robert Nissenson
-
依托单位:
CLONING OF THE PARATHYROID HORMONE RECEPTOR CDNA
-
批准号:3243172
-
项目类别:
-
资助金额:$6.06万
-
财政年份:1991
-
负责人:Robert Nissenson
-
依托单位:
PARATHYROID HORMONE RECEPTORS IN KIDNEY AND BONE
-
批准号:2139546
-
项目类别:
-
资助金额:$15.73万
-
财政年份:1985
-
负责人:Robert Nissenson
-
依托单位:
PARATHYROID HORMONE RECEPTORS IN KIDNEY AND BONE
-
批准号:3153858
-
项目类别:
-
资助金额:$6.37万
-
财政年份:1985
-
负责人:Robert Nissenson
-
依托单位:
PARATHYROID HORMONE RECEPTORS IN KIDNEY AND BONE
-
批准号:2734035
-
项目类别:
-
资助金额:$22.72万
-
财政年份:1985
-
负责人:Robert Nissenson
-
依托单位:
PARATHYROID HORMONE RECEPTORS IN KIDNEY AND BONE
-
批准号:3233624
-
项目类别:
-
资助金额:$2.73万
-
财政年份:1985
-
负责人:Robert Nissenson
-
依托单位:
PARATHYROID HORMONE RECEPTORS IN KIDNEY AND BONE
-
批准号:3233629
-
项目类别:
-
资助金额:$16.12万
-
财政年份:1985
-
负责人:Robert Nissenson
-
依托单位:
海外基金